TESA/IPA

✨ Overview

Our high-quality TESA/IPA peptide blend is available in a 6mg/3mg size.  The product comes in a lyophilized powder form in a 3mL vial that requires Reconstitution Solution to reconstitute from solid to liquid form.

The TESA/IPA blend combines TESAMORELIN, a growth hormone–releasing hormone (GHRH) analogue, with IPAMORELIN, a selective growth hormone–releasing peptide (GHRP). This dual-pathway approach is frequently explored in research settings to examine amplified growth hormone (GH) signaling through complementary mechanisms.

Areas of Ongoing Exploration

• Dual GH pathway activation – Studied for combined stimulation of GH release via GHRH and ghrelin receptors.
• Body composition research – Investigated in models examining fat metabolism and GH-related pathways.
• Selective signaling studies – Explored for minimized impact on cortisol and prolactin compared to broader GHRPs.
• Metabolic signaling models – Considered in studies focused on GH influence on lipid and energy regulation.
  

Product Details

• Form: Lyophilized powder (for laboratory research)
• Amounts: 6mg TESA/3mg IPA per vial
• Purity: ≥ 98% (HPLC tested)
• Sequence: 44 amino acids (synthetic GHRH analogue)
• Molecular Weight: ~513.6 g/mol/~711.9 g/mol
• Intended Use: Laboratory research only

DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.